Last Price
16.76
Today's Change
-0.61 (3.51%)
Day's Change
16.41 - 17.46
Trading Volume
4,609,908
Overview
Market Cap
0
Shares Outstanding
0
Avg Volume
314,255
Avg Price (50 Days)
15.69
Avg Price (200 Days)
16.69
PE Ratio
-11.45
EPS
-1.46
Earnings Announcement
10-Nov-2020
Previous Close
17.37
Open
17.29
Day's Range
16.41 - 17.46
Year Range
11.77 - 26.0
Trading Volume
4,611,685
Price Change Highlight
1 Day Change
0.00%
5 Day Change
0.00%
1 Month Change
0.00%
3 Month Change
0.00%
6 Month Change
0.00%
Ytd Change
0.00%
1 Year Change
0.00%
3 Year Change
0.00%
5 Year Change
0.00%
10 Year Change
0.00%
Max Change
0.00%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Technical & System Software
Description:
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
War World 3?
Poll Closed Upcoming PollIs WW3 coming?
Select only one answer
Yes, we are very close to it!
1 vote(s)
50.00%
No, we are not there yet!
0 vote(s)
0%
Possible a regional war - not full scale WW3
1 vote(s)
50.00%
1713671999000
Top Articles
1
CEO Morning Brief
Canada Hikes Capital Gains Tax to Raise Billions for Housing
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
